Vivera Pharmaceuticals Inc., its CEO, and another company he controlled that have already been found liable for securities fraud over cannabis-derived products should disgorge about $2.1 million, the SEC told a federal court.
The CEO should additionally pay a nearly $240,000 civil penalty and be barred from serving as an officer or director for five years, the Securities and Exchange Commission said Monday in a filing with the US District Court for the Central District of California. The total of the disgorgement, interest, and penalty would be more than $2.5 million.
Attorneys for Vivera, CEO Paul Edalat, and EFT Global ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.